SHBI
Shore Bancshares, Inc. · Financials · Banks - Regional
At close
$18.58
+$0.00 (+0.01%) Close
Pre-market $18.58 −$0.00 (−0.01%) 5:16 PM ET
Prev close $18.58
Open $18.59
Day high $18.59
Day low $18.58
Volume 236,015
Avg vol 254,903
Mkt cap
$620.82M
P/E ratio
10.93
FY Revenue
$339.15M
EPS
1.70
Gross Margin
64.52%
Sector
Financials
AI report sections
SHBI
Shore Bancshares, Inc.
Shore Bancshares Inc exhibits an upward price trend over 1–12 months supported by bullish technical signals and price near the top of its 52-week range. Fundamentally, the company shows positive but modest revenue and earnings growth, healthy margins, and solid free cash flow generation with low balance-sheet leverage, while its valuation multiples appear moderate relative to its profitability profile. Key risks include elevated momentum readings such as a high RSI, breakout-type technical patterns that can increase pullback risk, and only modest growth in top-line revenue.
AI summarized at 2:04 PM ET, 2026-02-03
AI summary scores
INTRADAY: 72 SWING: 78 LONG: 74
Volume vs average
Intraday (cumulative)
+21% (Above avg)
Vol/Avg: 1.21×
RSI
52.45 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.00 (Strong)
MACD: -0.00 Signal: -0.00
Short-Term
-0.13 (Weak)
MACD: 0.16 Signal: 0.29
Long-Term
-0.08 (Weak)
MACD: 0.47 Signal: 0.55
Intraday trend score 46.52

Latest news

SHBI 12 articles Positive: 0 Neutral: 1 Negative: 0
Neutral Benzinga • Prnewswire
Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share

Shore Bancshares, Inc. (NASDAQ: SHBI) announced that its Board of Directors has declared a quarterly common stock dividend of $0.12 per share, payable on March 18, 2026 to stockholders of record as of March 4, 2026. The announcement reflects the company's continued commitment to returning capital to shareholders.

SHBI dividend quarterly Shore Bancshares shareholder returns financial holding company
Sentiment note

The dividend announcement is a routine corporate action indicating stable operations and shareholder-friendly capital allocation. However, the stock price declined 2.69% on the announcement date, suggesting market sentiment may be influenced by broader economic concerns or company-specific factors rather than the dividend itself. The announcement is factual and positive in isolation but does not indicate growth or improvement.

Unknown Zacks Investment Research • Zacks Equity Research
Shore Bancshares (SHBI) Tops Q1 Earnings Estimates

Shore Bancshares (SHBI) delivered earnings and revenue surprises of 24.24% and 4.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

SHBI CZNC
Unknown Zacks Investment Research • Zacks Equity Research
Evans Bancorp (EVBN) Lags Q1 Earnings and Revenue Estimates

Evans Bancorp (EVBN) delivered earnings and revenue surprises of -8.70% and 0.16%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

EVBN SHBI
Unknown Zacks Investment Research • Zacks Equity Research
Univest (UVSP) Tops Q1 Earnings and Revenue Estimates

Univest (UVSP) delivered earnings and revenue surprises of 25% and 7.93%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

UVSP SHBI
Unknown Zacks Investment Research • Zacks Equity Research
Shore Bancshares (SHBI) Soars 7.3%: Is Further Upside Left in the Stock?

Shore Bancshares (SHBI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

SHBI MSBI
Unknown Zacks Investment Research • Zacks Equity Research
Shore Bancshares (SHBI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Shore Bancshares (SHBI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SHBI SMBK
Unknown Zacks Investment Research • Zacks Equity Research
Fulton Financial (FULT) Beats Q3 Earnings and Revenue Estimates

Fulton Financial (FULT) delivered earnings and revenue surprises of 7.50% and 2.05%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

FULT SHBI
Unknown Benzinga • Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023

Upgrades Ladenburg Thalmann upgraded the previous rating for Edison International (NYSE:EIX) from Sell to Neutral. Edison Intl earned $1.01 in the second quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of $74.92 and a 52-week-low of $54.51. At the end of the last trading period, Edison Intl closed at $69.76. For Hannon Armstrong Sustainable Infrastructure Capital Inc (NYSE:HASI), B of A Securities upgraded the previous rating of Neutral to Buy. Hannon Armstrong earned $0.53 in the second quarter, compared to $0.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of $44.41 and a 52-week-low of $21.31. Hannon Armstrong closed at $23.12 at the end of the last trading period. Janney Montgomery Scott upgraded the previous rating for Shore Bancshares Inc (NASDAQ:SHBI) from Neutral to Buy. For the second quarter, Shore Bancshares had an EPS of $0.25, compared to year-ago quarter EPS of $0.39. The current stock performance of Shore Bancshares shows a 52-week-high of $20.49 and a 52-week-low of $10.65. Moreover, at the end of the last trading period, the closing price was at $11.39. Oppenheimer upgraded the previous rating for Redfin Corp (NASDAQ:RDFN) from Underperform to Perform. Redfin earned $0.25 in the second quarter, compared to $0.73 in the year-ago quarter. The stock has a 52-week-high of $17.68 and a 52-week-low of $3.08. At the end of the last trading period, Redfin closed at $10.16. According to Raymond James, the prior rating for CareDx Inc (NASDAQ:CDNA) was changed from Market Perform to Outperform. CareDx earned $0.18 in the second quarter, compared to $0.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.54 and a 52-week-low of $6.22. CareDx closed at $9.35 at the end of the last trading period. According to Morgan Stanley, the prior rating for Pharvaris NV (NASDAQ:PHVS) was changed from Equal-Weight to Overweight. Pharvaris earned $0.69 in the second quarter, compared to $0.40 in the year-ago quarter. The stock has a 52-week-high of $21.71 and a 52-week-low of $1.80. At the end of the last trading period, Pharvaris closed at $18.42. RBC Capital upgraded the previous rating for Hexcel Corp (NYSE:HXL) from Sector Perform to Outperform. In the second quarter, Hexcel showed an EPS of $0.50, compared to $0.33 from the year-ago quarter. The current stock performance of Hexcel shows a 52-week-high of $79.08 and a 52-week-low of $50.25. Moreover, at the end of the last trading period, the closing price was at $69.11. For NextDecade Corp (NASDAQ:NEXT), Stifel upgraded the previous rating of Hold to Buy. NextDecade earned $0.23 in the first quarter, compared to $0.14 in the year-ago quarter. The current stock performance of NextDecade shows a 52-week-high of $8.94 and a 52-week-low of $3.92. Moreover, at the end of the last trading period, the closing price was at $5.53. See all analyst ratings upgrades. Downgrades According to Laidlaw & Co., the prior rating for Alaunos Therapeutics Inc (NASDAQ:TCRT) was changed from Buy to Hold. In the second quarter, Alaunos Therapeutics showed an EPS of $0.04, compared to $0.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.01 and a 52-week-low of $0.38. Alaunos Therapeutics closed at $0.39 at the end of the last trading period. According to SVB Leerink, the prior rating for Galecto Inc (NASDAQ:GLTO) was changed from Outperform to Market Perform. Galecto earned $0.41 in the second quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $3.70 and a 52-week-low of $1.06. At the end of the last trading period, Galecto closed at $2.34. For Chicken Soup for the Soul Entertainment Inc (NASDAQ:CSSE), Craig-Hallum downgraded the previous rating of Buy to Hold. For the second quarter, Chicken Soup for the Soul had an EPS of $1.50, compared to year-ago quarter EPS of $1.28. The stock has a 52-week-high of $13.44 and a 52-week-low of $0.94. At the end of the last trading period, Chicken Soup for the Soul closed at $1.01. For Design Therapeutics Inc (NASDAQ:DSGN), Wedbush downgraded the previous rating of Outperform to Neutral. Design Therapeutics earned $0.36 in the second quarter, compared to $0.27 in the year-ago quarter. The stock has a 52-week-high of $26.30 and a 52-week-low of $4.90. At the end of the last trading period, Design Therapeutics closed at $7.33. According to Alliance Global Partners, the prior rating for Chicken Soup for the Soul Entertainment Inc (NASDAQ:CSSE) was changed from Buy to Neutral. Chicken Soup for the Soul earned $1.50 in the second quarter, compared to $1.28 in the year-ago quarter. The stock has ...Full story available on Benzinga.com

PBF NFGC TCRT AVID Upgrades Downgrades Initiation Intraday Update
Unknown Zacks Investment Research • Zacks Equity Research
Shore Bancshares (SHBI) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Shore Bancshares (SHBI) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

SHBI
Unknown Zacks Investment Research • Zacks Equity Research
Shore Bancshares (SHBI) Misses Q2 Earnings and Revenue Estimates

Shore Bancshares (SHBI) delivered earnings and revenue surprises of -21.88% and 8.13%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

SHBI RDFN
Unknown Zacks Investment Research • Zacks Equity Research
Peapack-Gladstone (PGC) Q2 Earnings and Revenues Lag Estimates

Peapack-Gladstone (PGC) delivered earnings and revenue surprises of -10% and 4.44%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

PGC SHBI
Unknown Zacks Investment Research • Zacks Equity Research
Analysts Estimate Shore Bancshares (SHBI) to Report a Decline in Earnings: What to Look Out for

Shore Bancshares (SHBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SHBI
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal